ReviewFrontiers in oncology2025
The advantages of TCM in the treatment of gynecologic malignancies.
Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Research on the role and mechanism of FAT4 in the development and progression of tumor and non-tumor diseases.Discover oncology · 2026Review
- Natural Products in Endometrial Cancer: Molecular Mechanisms, Preclinical Evidence, and Clinical Perspectives.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gynecological malignancies are characterized by high morbidity and mortality rates. With the development of society, the status of women continues to improve, yet the social pressure they bear increases daily. The incidence rate of gynecological malignancies in the female population has always remained at a high level, and the age of onset has shown a trend of getting younger. Common gynecological malignancies include cervical cancer, ovarian cancer, and endometrial cancer. Alarmingly, over 70% of patients are diagnosed at an advanced stage. This disease is mainly treated through surgery and radiotherapy, but there is still a relatively high recurrence rate after treatment. In recent years, with the development of traditional Chinese medicine (TCM), the advantages of TCM in the treatment of gynecological malignancies have gradually emerged. The entry of TCM into the treatment of Gynecologic malignancies is a tumor treatment method that has received close attention from the international medical community in recent times. TCM can be used throughout the whole process of tumor treatment. Combining Western medicine at different stages of the tumor, or giving different Chinese medicines alone, can minimize the toxic side effects of Western medicine treatment, alleviate symptoms, prolong survival and improve the quality of survival. Therefore, combining traditional Chinese medicine to provide individualized treatment for patients may become a better approach to cancer treatment. This article reviews the status and important role of TCM in gynecological malignancies in the hope of exploring new treatment modalities to mitigate the impact of gynecological malignancies on women's health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.